Johnson & Johnson’s (JNJ) stock price has fallen approximately 13% since the beginning of the year. However, operating earnings are expected to increase modestly while operating cash flow is expected to increase 45% or more after dropping 1% in 2020 and 9% in 2022.

Nevertheless, JNJ’s dividend is well covered and the company’s balance sheet contains enough cash and short-term investments to cover any contingent liabilities from several lawsuits on talcum powder and opioids.

From a valuation perspective, JNJ has fallen into fair value territory, but we do not consider it dramatically undervalued.

Consequently, for those investors who are looking for high quality, and above-average dividend yield approaching 3%, JNJ may be just the ticket. The point is that the future return is expected to be positive but single digit. Considering the quality of this AAA rated behemoth with a strong balance sheet, it could be attractive to many types of investors.

We consider JNJ a solid hold and a reasonably valued buy at this time. In order to receive a true margin of safety, Johnson & Johnson would have to fall further from here which may or may not occur. Caveat emptor.

FAST Graphs Analyze Out Loud Video

— Chuck Carnevale

Collect up to 5 dividend checks per week [sponsor]
Hi, I'm Tim Plaehn, and I just did the math in my own, real-money portfolio. I'll be collecting 70 dividend checks this quarter. That's nearly 5 per week on average. Automatically… no trading, no options, no work. You don't need a lot of money. You can be retired or near retirement... Either way, I'll show you my #1 plan to quickly collect dividends like clockwork from high-quality, cash-flowing business. Click here to learn how to collect up to 5 dividends a week.

Source: FAST Graphs